The stock of Enfusion Inc. (NYSE:ENFN) last traded at $13.77, down -0.51% from the previous session.
Data from the available sources indicates that Enfusion Inc. (NYSE:ENFN) is covered by 6 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $16.00 and a low of $13.00, we find $14.00. Given the previous closing price of $13.84, this indicates a potential upside of 1.16 percent. ENFN stock price is now 11.93% away from the 50-day moving average and 10.89% away from the 200-day moving average. The market capitalization of the company currently stands at $1.47B.
In total, 4 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $14.40 as their price target over the next twelve months.
With the price target reduced from $17 to $15, BofA Securities Downgraded its rating from Buy to Neutral for Enfusion Inc. (NYSE: ENFN). , while ‘Stifel’ rates the stock as ‘Buy’.
Insiders disposed of 415,955 shares of company stock worth roughly $5.73 million over the past 1 year. A total of 3.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ENFN stock. A new stake in Enfusion Inc. shares was purchased by MILLENNIUM MANAGEMENT LLC during the first quarter worth $8,206,000. NORGES BANK invested $6,825,000 in shares of ENFN during the first quarter. In the first quarter, NEXT CENTURY GROWTH INVESTORS LLC acquired a new stake in Enfusion Inc. valued at approximately $6,056,000. WASATCH ADVISORS INC acquired a new stake in ENFN for approximately $4,216,000. PUTNAM INVESTMENTS LLC purchased a new stake in ENFN valued at around $448,000 in the second quarter.
With an opening price of $13.35 on Monday morning, Enfusion Inc. (NYSE: ENFN) set off the trading day. During the past 12 months, Enfusion Inc. has had a low of $7.80 and a high of $23.21. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 8.00, and a quick ratio of 8.00. The fifty day moving average price for ENFN is $12.30 and a two-hundred day moving average price translates $12.42 for the stock.
The latest earnings results from Enfusion Inc. (NYSE: ENFN) was released for Jun, 2022. The net profit margin was -13.00% and return on equity was -29.60% for ENFN. The company reported revenue of $39.15 million for the quarter, compared to $29.05 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 34.79 percent. For the current quarter, analysts expect ENFN to generate $38.54M in revenue.
Enfusion Inc.(ENFN) Company Profile
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.